M. Rybczynska et al., Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities, BIOCH PHARM, 62(6), 2001, pp. 765-772
We investigated endocytosis activity, uptake of miltefosine (hexadecylphosp
hocholine), phospholipid and cholesterol content, the cell cycle, and apopt
osis in 13 tumor cell lines (MCF7, MCF7/ADR, KB-3-1, KB-8-5, KB-Cl, HeLa, H
eLa-MDR1-G185, HeLa-MDR1-V185, CCRF/CEM, CCRF/VCR 1000, CCRF/ADR5000, HL-60
, HL-60/AR) with different sensitivities to treatment with the antitumor ph
ospholipid analogues miltefosine and D-21266 (octadecyl-(N,N-dimethyl-piper
idino-4-yl)-phosphate). In this panel of cell lines, MDR1 (multidrug resist
ance gene 1)- and MRP1 (multidrug resistance-associated protein)-expressing
cells were found to be slightly more resistant to both compounds than sens
itive parental cells. No correlation was found between resistance to miltef
osine and endocytosis, intracellular concentration of miltefosine, the phos
pholipid and cholesterol content, induction of apoptosis, or cell cycle alt
erations in all the cell lines tested. Wild-type p53 containing WMN Burkitt
's lymphoma cells and wild type p53-deficient CA46 exhibited similar sensit
ivities to miltefosine. The low percentage of apoptosis induced in MCF7 cel
ls lacking caspase 3 indicated that caspase 3 seems to play an essential ro
le in miltefosine-induced apoptosis. (C) 2001 Elsevier Science Inc. All rig
hts reserved.